DE RIZ, MILENA ALESSANDRA
 Distribuzione geografica
Continente #
EU - Europa 5.476
NA - Nord America 4.268
AS - Asia 4.207
SA - Sud America 442
AF - Africa 128
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.574
Nazione #
US - Stati Uniti d'America 4.037
GB - Regno Unito 1.527
CN - Cina 1.287
SG - Singapore 1.229
IT - Italia 1.012
DE - Germania 721
SE - Svezia 476
VN - Vietnam 464
RU - Federazione Russa 329
BR - Brasile 324
FR - Francia 290
HK - Hong Kong 282
IN - India 273
CA - Canada 171
TR - Turchia 167
NL - Olanda 159
UA - Ucraina 157
ES - Italia 152
IE - Irlanda 130
PL - Polonia 111
KR - Corea 107
FI - Finlandia 98
JP - Giappone 94
IR - Iran 65
DK - Danimarca 63
EU - Europa 57
GR - Grecia 55
CO - Colombia 49
ID - Indonesia 48
AU - Australia 47
CI - Costa d'Avorio 46
BE - Belgio 45
MX - Messico 37
CH - Svizzera 31
AR - Argentina 25
MA - Marocco 25
RO - Romania 25
BD - Bangladesh 21
JO - Giordania 21
IQ - Iraq 19
CZ - Repubblica Ceca 18
AT - Austria 17
IL - Israele 17
ZA - Sudafrica 15
CY - Cipro 13
PK - Pakistan 13
SA - Arabia Saudita 13
PT - Portogallo 12
VE - Venezuela 11
CL - Cile 10
EG - Egitto 10
UZ - Uzbekistan 10
PE - Perù 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
EC - Ecuador 8
NO - Norvegia 8
PH - Filippine 8
KZ - Kazakistan 7
LT - Lituania 7
TW - Taiwan 7
AZ - Azerbaigian 5
DZ - Algeria 5
JM - Giamaica 5
KE - Kenya 5
LV - Lettonia 5
NP - Nepal 5
NZ - Nuova Zelanda 5
CU - Cuba 4
HU - Ungheria 4
LU - Lussemburgo 4
PY - Paraguay 4
QA - Qatar 4
AM - Armenia 3
BG - Bulgaria 3
ET - Etiopia 3
MD - Moldavia 3
MY - Malesia 3
PA - Panama 3
TJ - Tagikistan 3
BB - Barbados 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BW - Botswana 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
MK - Macedonia 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CG - Congo 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
Totale 14.615
Città #
Southend 1.266
Singapore 769
Ashburn 425
Chandler 325
Milan 249
Hong Kong 241
Beijing 230
San Jose 164
Princeton 142
Wilmington 142
Seattle 141
Ho Chi Minh City 129
Hanoi 125
Dublin 122
Frankfurt am Main 122
Santa Clara 119
Council Bluffs 116
Ann Arbor 109
Jacksonville 100
Los Angeles 100
Dallas 95
Redwood City 94
Bengaluru 83
Nanjing 83
New York 82
Toronto 81
Berlin 76
Woodbridge 74
Fairfield 69
Warsaw 67
Lauterbourg 65
Shanghai 63
Houston 61
Hefei 57
Kent 56
Redmond 56
Moscow 54
Mountain View 53
Ottawa 52
Tokyo 52
Des Moines 47
Abidjan 46
The Dalles 46
Dearborn 45
Boardman 44
Jinan 44
Somerville 44
Rome 43
Helsinki 42
Buffalo 40
Cambridge 39
Guangzhou 39
Athens 38
Sakarya 37
Andover 35
Bogotá 35
Phoenix 35
Shenyang 35
São Paulo 35
Madrid 32
Serra 32
Tianjin 31
London 28
Hangzhou 27
Jakarta 26
Margão 26
Nanchang 25
Da Nang 24
Brussels 23
Chicago 23
Fuzhou 23
Columbus 22
Paris 20
Duncan 19
Haiphong 19
Istanbul 19
Cangzhou 18
Dong Ket 18
Munich 18
Norwalk 18
Nuremberg 18
Turin 18
Barcelona 17
Brescia 17
Jiaxing 17
Wuhan 17
Changsha 16
Bari 15
Florence 15
Fremont 15
Zhengzhou 15
Adelaide 14
Amman 14
Nürnberg 14
Prague 14
Kiez 13
Orem 13
Birmingham 12
Casablanca 12
Chengdu 12
Totale 8.067
Nome #
Transcranial direct current stimulation (tDCS) for fatigue in multiple sclerosis 1.244
FATTORI DI RISCHIO GENETICI NELLA MALATTIA DI ALZHEIMER E NELLA DEMENZA FRONTOTEMPORALE: STUDIO DI ASSOCIAZIONE DI GENI CANDIDATI POSIZIONALI E FUNZIONALI 635
Balò’s concentric sclerosis : still to be considered as a variant of multiple sclerosis? 506
CSF β-amyloid predicts prognosis in patients with multiple sclerosis 505
Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression 468
Role of hnRNP-A1 and miR-590-3p in neuronal death : genetics and expression analysis in patients with Alzheimer’s disease and frontotemporal lobar degeneration 275
P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis 259
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients 257
Changes in vitamin B12 and tumour necrosis factor-a levels in cerebrospinal fluid of patients with different subtypes of multiple sclerosis 251
Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease 235
Candidate gene analysis of semaphorins in patients with Alzheimer's disease 233
CSF β-amyloid predicts early cerebellar atrophy and is associated with a poor prognosis in multiple sclerosis 230
Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males 227
Loss of cobalamin-mediated regulation leads to decreased EGF and increased soluble CD40 levels in cerebrospinal fluid of patients with multiple sclerosis 225
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes 222
Progranulin gene variability in a population of 239 patients with primary progressive multiple sclerosis 218
IP-10 haplotypes and multiple sclerosis : association and correlation with clinical course 213
CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis 213
Progranulin genetic variability in primary progressive multiple sclerosis. 212
Selectin gene cluster genetic variation: association study in two independent multiple sclerosis populations. 209
Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis 209
Reversible Parkinson's Dementia associated with withdrawal of androgen-deprivation therapy for prostate cancer 209
Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis 208
Progranulin gene mutation scanning in multiple sclerosis patients with cognitive impairment 204
Role of hnRNP-A1 and miR-590-3p in Neuronal Death : Genetics and Expression Analysis in Patients with Alzheimer Disease and Frontotemporal Lobar Degeneration 199
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis : correlation with CSF β-amyloid levels and brain volumes 198
Progranulin gene mutation scanning in Multiple Sclerosis patiens with cognitive impairment. 197
CSF β-amyloid and white matter damage: A new perspective on Alzheimer's disease 197
IP-10 haplotypes and multiple sclerosis : association and correlation with clinical course 196
GRN rs5848 in neurodegeneration: a role in axonal damage? 196
A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation 195
Selectin gene cluster genetic variation: association study in two independent multiple sclerosis populations. 193
Gender-specific influence of the chromosome 16 gene cluster on the susceptibility to multiple sclerosis 191
Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference? 190
Interleukin-1 beta and interferon-gamma induce proliferation and apoptosis in cultured Schwann cells 188
Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease? 186
C9ORF72 repeat expansion not detected in patients with multiple sclerosis 185
MDC/CCL22 intrathecal levels in patients with multiple sclerosis 184
GSK3β genetic variability in patients with Multiple Sclerosis 184
Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis 182
Expression profile of miRNAs involved in CD4+ lymphocyte activation and differentiation in patients with multiple sclerosis 182
miR-150-5p and let-7b-5p in Blood Myeloid Extracellular Vesicles Track Cognitive Symptoms in Patients with Multiple Sclerosis 180
Cerebrospinal Fluid Biomarkers in Progranulin Mutations Carriers 180
Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to multiple sclerosis 179
SELP and SELPLG single nucleotide polymorphisms in multiple sclerosis 179
Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation 179
Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to multiple sclerosis 177
Gender-specific influence of the chromosome 16 chemokine genecluster on the susceptibility to Multiple Sclerosis 177
GRN rs5848 polymorphism: a role in neurodegeneration? 177
CXCL10 haplotypes and multiple sclerosis : association and correlation with clinical course 173
Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy 172
SELPLG and SELP single-nucleotide polymorphisms in multiple sclerosis 170
MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers 170
Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to multiple sclerosis 170
Effect of fingolimod treatment on circulating miR-15b, miR23a and miR-223 levels in patients with multiple sclerosis 169
Inflammatory expression profile in peripheral blood mononuclear cells from patients with Nasu-Hakola Disease 164
The effects of transcranial direct current stimulation (tDCS) on fatigue in Multiple Sclerosis 160
Merkel cell carcinoma in a patient with relapsing-remitting multiple sclerosis treated with fingolimod 158
Expression and genetic analysis of miRNAs involved in CD4+cell activation in patients with multiple sclerosis 156
Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study 150
Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis 149
Expression and genetic analysis of microRNAs involved in multiple sclerosis 149
Xerophthalmia, xerostomia and primary Sjögren’s syndrome in multiple sclerosis patients treated with immunomodulating drugs : an Italian multicentre study 133
Low CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosis [Low CSF beta-amyloid levels predict early regional grey matter atrophy in multiple sclerosis] 133
Role of Chitinase 3-like 1 as a Biomarker in Multiple Sclerosis: A Systematic Review and Meta-analysis 129
Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic Syndrome 122
Multiple sclerosis : BAFF and CXCL13 in cerebrospinal fluid 114
Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis : the Italian experience 87
null 3
Totale 15.169
Categoria #
all - tutte 38.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.876


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021486 0 0 0 0 0 0 0 0 0 96 211 179
2021/20221.041 82 78 40 53 82 70 85 60 142 100 74 175
2022/20231.358 166 184 119 151 119 210 53 83 143 31 63 36
2023/20241.034 37 79 49 77 282 57 52 67 52 83 88 111
2024/20252.179 69 187 50 256 209 94 110 216 122 239 183 444
2025/20263.662 444 248 338 368 426 250 645 180 473 290 0 0
Totale 15.169